Influence of harmaline on the ability of pargyline to alter catecholamine metabolism in rats
- 1 June 1981
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 30 (11) , 1295-1298
- https://doi.org/10.1016/0006-2952(81)90312-9
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- THE EFFECTS OF CHRONIC REGIMENS OF CLORGYLINE AND PARGYLINE ON MONOAMINE METABOLISM IN THE RAT BRAINJournal of Neurochemistry, 1979
- Enhanced selectivity of pargyline as an inhibitor of type B monoamine oxidase in harmaline-treated ratsLife Sciences, 1978
- Monoamine oxidase A and B: A useful concept?Biochemical Pharmacology, 1978
- Lowering of epinephrine concentration in rat brain by 2, 3-dichloro-α-methyl-benzylamine, an inhibitor of norepinephrine N-methyltransferaseBiochemical Pharmacology, 1977
- Preferential deamination of dopamine by an A type monoamine oxidase in rat brainNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1976
- The monoamine oxidase B inhibitor deprenyl potentiates phenylethylamine behaviour in rats without inhibition of catecholamine metabolite formationEuropean Journal of Pharmacology, 1975
- Chemistry and Enzymology of k cat InhibitorsScience, 1974
- Another look at the monoamine oxidases and the monoamine oxidase inhibitor drugsLife Sciences, 1974